Evidence map›Paper›PMID 30036388›Full record

ArticlePloS one2018

Accumulation of bioactive metabolites in cultivated medical Cannabis.

Richard D Richins, Laura Rodriguez-Uribe, Kiah Lowe, Rebekah Ferral, Mary A O'Connell

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. The Use ofCannabis and cannabinoid research · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Equine Crofton Weed (Animals : an open access journal from MDPI · 2023
    Review
  11. Article
  12. Article
  13. Isolation of Biologically Active Compounds fromAntioxidants (Basel, Switzerland) · 2023
    Article
  14. Analysis of Cannabinoids in Biological Specimens: An Update.International journal of environmental research and public health · 2023
    Review
  15. Article
  16. Article
  17. Secondary Terpenes inBiomedicines · 2022
    Review
  18. Article
  19. Article
  20. Targeting natural products against SARS-CoV-2.Environmental science and pollution research international · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Richard D RichinsDepartment of Plant and Environmental Sciences, New Mexico State University, Las Cruces, New Mexico, United States of America.
Laura Rodriguez-UribeDepartment of Plant and Environmental Sciences, New Mexico State University, Las Cruces, New Mexico, United States of America.
Kiah LoweDepartment of Plant and Environmental Sciences, New Mexico State University, Las Cruces, New Mexico, United States of America.
Rebekah FerralDepartment of Plant and Environmental Sciences, New Mexico State University, Las Cruces, New Mexico, United States of America.
Mary A O'ConnellDepartment of Plant and Environmental Sciences, New Mexico State University, Las Cruces, New Mexico, United States of America.ORCID 0000-0003-4430-6733
New Mexico State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been an increased use of medical Cannabis in the United States of America as more states legalize its use. Complete chemical analyses of this material can vary considerably between producers and is often not fully provided to consumers. As phytochemists in a state with legal medical Cannabis we sought to characterize the accumulation of phytochemicals in material grown by licensed commercial producers. We report the development of a simple extraction and analysis method, amenable to use by commercial laboratories for the detection and quantification of both cannabinoids and terpenoids. Through analysis of developing flowers on plants, we can identify sources of variability of floral metabolites due to flower maturity and position on the plant. The terpenoid composition varied by accession and was used to cluster cannabis strains into specific types. Inclusion of terpenoids with cannabinoids in the analysis of medical cannabis should be encouraged, as both of these classes of compounds could play a role in the beneficial medical effects of different cannabis strains.

Indexed as

CannabinoidsCannabisCrop ProductionEnvironment, ControlledFlowersGene Expression Regulation, PlantMedical MarijuanaPhytochemicalsPlant ExtractsPlant LeavesSpecies SpecificityTerpenesCannabinoidsMedical MarijuanaPhytochemicalsPlant ExtractsTerpenes

Identifiers

PMID30036388
PMCPMC6056047
OpenAlexW2883500808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.